US earnings delivered 'well above expectations'
NBFIs on ‘strongest footing in years’
'Lack of domestic investment was not always the case'
Strategic shift carries 'major implications'
Questions on whether bar is set high enough
Five big biotech themes
Performance review of multi-asset funds